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Abstract
The heart and the immune system are highly integrated systems cross-talking through 
cytokines, hormones and neurotransmitters. Their balance can be altered by numerous 
physical or psychological stressors leading to the onset of inflammation, endothelial 
dysfunction and tissue damage. Here, we review the main players and mechanisms 
involved in the field. A new research paradigm, which considers also novel contributors, like 
endothelial cells, is needed to better understand the pathophysiology of immune-mediated 
cardiovascular disorders and beyond.
Endothelial dysfunction, heart and 
immune system
The endothelium is an active paracrine, endocrine, and 
autocrine organ (1) necessary for the regulation of the 
vascular tone and homeostasis. The endothelial function 
is considered a ‘barometer’ of cardiovascular health and is 
useful in prognosis evaluation and in therapeutic patient 
management (2, 3, 4). In fact, not only cardiovascular 
risk factors (2, 3, 4), but also several neuroendocrine 
and immunometabolic diseases switch the endothelial 
phenotype from health to disease-causing endothelial 
dysfunction (5). Indeed, the dysfunction of endothelial 
cells (ECs) represents the earliest key step in the 
development of most cardiovascular diseases. However, 
the molecular mechanisms that disrupt endothelial 
homeostasis remain unclear. Evidence indicates that, ECs 
are not simply bystanders lying between the circulating 
blood and the vessel wall components, but are the 
gatekeepers of a variety of signaling pathways actively 
controlling vascular integrity and exchanges between 
the circulation and different tissues and organs (6). 
Moreover, once endothelial dysfunction arises, it can be 
regarded as a systemic condition (7) affecting the coronary 
as well as the peripheral vasculature.
A major determinant of endothelial health is the 
immune system. In fact, endothelial dysfunction is a 
hallmark in several immuno-mediated pathologies (i.e. 
vasculitis, myocarditis, thyroiditis, psoriasis, systemic 
lupus erythematosus, antiphospholipid syndrome, 
idiopathic inflammatory myositis, mixed connective 
tissue diseases, rheumatoid arthritis, systemic sclerosis, 
Sjögren’s syndrome, graft disease after transplantation 
etc.) (6). The role of the innate immune system 
(monocytes and macrophages) together with neutrophils 
and lymphocytes (6) has also been well explored in 
relation to the onset and development of atherosclerosis. 
Interestingly, the electrical activity of the cardiac 
conduction tissue is also modulated by the immune 
system with a proven immunological component driving 
some rhythm and conduction disorders (8). Finally, after 
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any insult the immune response may trigger either repair 
or regeneration processes in physiologic conditions or 
fibrosis in pathologic ones (6).
Nowadays, the heart itself is seen as an important 
immune station, able to fine-tune the function of 
the immune system by means of specific cardiokines 
(i.e. natriuretic peptides, tumor necrosis factor-alpha, 
transforming growth factor-beta, growth differentiation 
factor-15, activin-A, myostatin, adrenomedullin, and 
endocannabinoids) (1). It is becoming increasingly clear 
that a continuous flow of molecular information is 
exchanged between the cardiovascular and the immune 
system (9).
However, how the communication between the 
cardiovascular and the immune system takes place is not 
fully understood.
The immune system beyond the fight 
against infections: the sense of danger
Our understanding of the immune system has evolved 
over the past decades with the recognition that this is a 
dynamically regulated organ not only able to discriminate 
between ‘self’ and ‘non-self’ and fight against pathogenic 
microorganisms, but it plays a pivotal role in a variety of 
physio-pathological processes from organ development 
to tissue homeostasis and repair (6) (Fig. 1). Although 
not commonly considered part of the immune system, 
stromal and mesenchymal cells like fibroblasts and 
endothelial cells play crucial immunological functions. 
Moreover, the inflammatory status of the tissue 
environment is important in defining the type of response 
to any antigen and the immune system is crucial for the 
maintenance and restoration of tissue homeostasis in 
both sterile and infectious situations.
As we detailed elsewhere (2) a novel interpretation 
framework starts with the concept that the immune system 
recognizes as ‘danger’ all potential harms causing tissue 
stress or damage. According to this model, stressed tissues 
release alarm signals that activate antigen-presenting 
cells. This is the first check-point to activate immune 
responses. During the cellular response to stress (called 
‘universal cell danger response’ (CDR), damaged cells 
and the immune system activate a sterile inflammation 
(or inflammasome)). Danger signals are recognized by 
the innate immune system through different receptors 
(pathogen recognition receptors (PRR) such as Toll-
like receptors (TLR), nod-like receptors and receptors 
for advanced glycation end-products) that activate the 
production of cytokines and attract leukocytes to the site 
of lesion (2, 3, 4). If the CDR persists abnormally beyond 
the injury resolution, the whole body metabolism and 
the gut microbiome will be disturbed, leading to multiple 
organ dysfunction and the onset of chronic diseases 
(10, 11, 12, 13, 14, 15, 16). This phenomenon is 
accompanied by the activation of the psycho-neuro-
endocrine-immunitary (PNEI) network.
Figure 1
The figure depicts the fundamental roles of the 
immune system beyond host defense. (A) The 
immune system eliminates microbes in case of 
injury at barrier sites (e.g. skin) or primary 
infectious tissue damage (e.g. viral or bacterial 
myocarditis). (B) The immune system is essential 
for allostasis (2, 3, 4), development and 
reproduction. Sterile tissue damage such as 
psychological (36) or physical trauma (37), 
mechanical stress (38) or ischemia/reperfusion 
injury (e.g. myocardial infarct) induces an 
inflammatory reaction promoting wound healing 
and/or regenerative mechanisms. Necrotic cells in 
damaged tissue release damage/danger-
associated molecular patterns (DAMPs) such as 
HMGB1, IL-33, ATP, heat-shock proteins, nucleic 
acids and ECM degradation products. Microbes 
are recognized by the immune system through 
their expression of pathogen-associated 
molecular patterns (PAMPs) such as LPS, flagellin, 
dsRNA and unmethylated motifs in DNA. ATP, 
adenosine triphosphate; ECM, extracellular 
matrix; HMGB1, high mobility group box 1.
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Cardiac myocytes, fibroblasts, endothelial 
cells, pericytes and cardiac tissue 
macrophages as a part of the ‘innate 
immune system’
Janeway described the existence of the ‘innate immunity’ 
as a simple, but rapid immune response (17), found in 
non-immunologic cell types and tissues. Indeed, the 
innate immunity is activated by the TLRs and is essential 
for rapid protection against infections. The downside 
of the innate response lies in its potential aspecific 
activation by proteins, RNA, and other endogenous 
ligands (called ‘alarmins’ or ‘danger signals’) that can 
lead to harmful cell and tissue inflammation/damage 
(6). Unfortunately, a number of essential and otherwise 
innocuous molecules activate different TLRs leading to 
inflammation accompanied by myocyte or ECs death/
injury and to organ dysfunction. Aberrant activation of 
TLR4 plays a significant role in cardiac injury. Other TLRs, 
including TLR2, seem also involved, although to a lesser 
extent (6).
Traditionally considered as non-immunologic 
cells, cardiac fibroblasts (CFs) are newly believed as 
the immunomodulatory hub of the heart (6). Under 
homeostatic conditions, immune cells and fibroblasts 
reside in the myocardial interstitium and sense micro-
environmental cues maintaining the extracellular matrix 
in homeostatic conditions. Upon an injury, such as 
ischemic events or pressure overload, cardiac fibroblasts 
cross-talk with various immune cells and modulate the 
activity of both innate and adaptive immune systems 
(18). Indeed, after an injury, CFs undergo a transformation 
acquiring a myofibroblast phenotype and contribute 
to cardiac fibrosis. This remodeling causes well-known 
pathological changes like heart chamber dilation, 
cardiomyocyte hypertrophy and apoptosis leading to 
heart failure. Fibrosis is a crucial pathophysiological 
process in the development of cardiovascular disease. 
Current research aims to histologically localize and trace 
the origins and fate of CFs in various diseases in order 
to better understand the molecular mechanisms of CF 
activation. Among others the transforming growth factor-
beta pathway, the angiotensin and endothelin system, 
the pathway of RhoA serum response factor myocardin-
related transcription factor but also the transient receptor 
potential channel network are emerging as fundamental 
players together with the connective tissue growth 
factor pathway, integrins and connexins networking and 
molecules of the adrenergic system. The crosstalk between 
these pathways and molecules seems to play an essential 
role in switching on the genetic machinery initiating 
profibrotic changes in the heart. Better understanding 
of these mechanisms will open new opportunities for 
development of targeted therapeutic approaches against 
cardiac fibrosis and its pathological contribution to 
disease progression (19, 20).
Another novel player is ECs. These cells communicate 
with immune cells through EC-secreted factors and 
endothelial dysregulation contributes directly to mediate 
immune responses at places of injury or infection (21). 
For instance, ECs are both culprits and victims during 
myocardial infarction. Although ECs tolerate hypoxia 
better than other cardiac resident cell types, their pro-
angiogenic activation causes loss of barrier function 
and edema formation sustaining the cardiac immune 
cell infiltration. Accordingly, ECs pro-inflammatory 
activation increases the expression of adhesion molecules 
and causes leukocyte infiltration. Excessive immune cell 
infiltration can be detrimental to the already damaged 
tissue. Loss of nitric oxide (NO) synthesis by ECs impairs 
vascular dilatation and this further aggravates vessel 
occlusions in the heart. In addition, endothelial activation 
promotes a pro-thrombotic state and is able to activate 
the neuroendocrine hypothalamic–pituitary–adrenal 
D(HPA) stress axis (22). Thus, the loss of endothelial-
mediated immunomodulation needs to be considered as 
detrimental as the impairment of the other better known 
endothelial properties, such as angiogenesis, hemostasis, 
and the regulation of vascular tone (6).
The role of pericytes in disease has been described 
in many organs, and pericyte dysfunction has been 
implicated in tumor angiogenesis, atherosclerosis and 
Alzheimer’s disease (6). Pericytes are a complex cell type 
playing many roles depending on the tissue they reside in 
(6). In addition to their well-established role in vascular 
formation, stabilization, remodeling, and function 
(pericytes transplantation techniques are even being 
tested to improve cardiac vasculature after myocardial 
infarction in animal models (23)), pericytes play a pivotal 
role in the immune response, attracting immune cells 
to the site of injury and regulating the migration of 
immune cells into the damaged tissue. Alterations of 
the fine-tuned interactions between pericytes and ECs, 
as documented in numerous genetic mouse models 
and certain human disease, result in severe and often 
lethal cardiovascular defects, diabetic microangiopathy, 
ectopic tissue calcification, stroke and dementia likely 
throughout the involvement of the transforming growth 
factor-beta pathway, TPBG (trophoblast glycoprotein) and 
the CXCL12/CXCR7/pERK axis (24), angiopoietins and 
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angiocrine signaling (25), platelet-derived growth factor 
network, spingosine-1-phosphate and Notch ligands and 
their respective receptors (26, 27).
As described by Alexei Ilinykh and Alexander 
R Pinto (6), cardiac tissue macrophages (cTMs) are 
phagocytic cardiac resident leukocytes that are 
activated by danger-associated molecular patterns 
(DAMPs). These cells, in concert with fibroblasts, 
platelets, and ECs, release cytokines that initiate 
an inflammatory cascade and recruit circulating 
leukocytes into the injured tissue. During inflammatory 
responses cTMs differentiate into the ‘M1’ or ‘classically 
activated’ macrophages and secrete proteolytic and 
inflammatory agents (such as IL-1β, TNFα, NO, and 
IL-6). Later on, pro-inflammatory macrophages are 
replaced by macrophages with an anti-inflammatory 
phenotype (commonly termed ‘alternatively activated’ 
or ‘M2’) that help healing resolution of the lesion. 
Interestingly, it has been recently demonstrated (28) 
that macrophages may be implicated in normal and 
aberrant cardiac electrical conduction. In fact, cardiac 
macrophages seem to promote electrical conduction 
in the atrioventricular node through connexin 43-gap 
junctions. On the other hand, deletion of connexin 43 
in macrophages or congenital lack of macrophages may 
delay the atrioventricular conduction and even cause 
an atrioventricular block.
Thus, cardiac myocytes, fibroblasts, ECs, pericytes and 
cTMs continuously exchange molecular/electrochemical 
information with the immune system keeping the 
cardiovascular and neuroendocrine-immune system in 
equilibrium (29). Indeed, stress of different nature can 
alter the cardio-immuno homeostasis with potential 
diseases onset (Fig. 2).
Figure 2
The human organism always tries to maintain its stability by adapting (allostasis) to external (physical and chemical) or internal (psychological) stimuli. In 
particular, stimuli are divided into physiological or non-physiological. Non-physiological stimuli (physical/chemical and psychological) are able to stress 
our psycho-neuro-endocrine-immune adaptation system (PNEI) (35) (left panel). Along with neurotransmitters, hormones and cytokines, also the human 
microbiome (and virome) plays an important role in the pathogenesis of many immune-mediated diseases, including cardiovascular disorders (29). The 
resulting immune activation can potentially affect all tissues. At the cardiovascular level, immune cells (activated either by a psychological or physical 
stressor) interact with endothelial cells, cardiac stromal cells and cardiomyocytes, which adapt their metabolism to support the ongoing inflammatory 
process (upper part right panel). In the heart (lower side of the right panel), the stress signal can mediate the activation of the intracellular transduction 
pathways linked to mTOR (39) and NfKB (40) genes through the mediators of the PNEI system (i.e hormones, neurotransmitters and cytokines). This will 
influence the cellular energy metabolism with high oxidative stress and damage from free radicals (41), misfolding of proteins (42) or their abnormal 
synthesis (alternative splicing) (43). Thus, cardiac cells expose danger signals that are detected by the immune system. The whole process can be 
resolved with regeneration/repair (depending on the tissue potential) in case of control and resolution of the acute stimulus or with tissue destruction in 
case of stress persistence and chronic processes. Of note, the ‘cardioimmune’ inflammatory activation can be activated by psychological stress and the 
stress activated patterns can be transmitted across generations via epigenetic modulation (44, 45).
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Psychic activity may modulate the crosstalk 
between the immune system and the  
heart and should be considered in the  
study of endothelial function and  
‘cardio-immuno’ diseases
The same inflammatory pathways briefly described in 
Figs 1 and 2 can also be activated in a ‘sterile’ way by 
mental stress (30). In fact, mental stress can lead to 
cellular damage with exposure of alarm molecules (i.e. 
beta 2 adrenergic receptors, protein kinase A, vascular 
endothelial growth factor, matrix metal proteinase-2 and 
9, S-100A1-9 proteins, DAMPs (heat shock protein-72, 
HMGB1, proteins RAE-1 and Mult1)) and the subsequent 
immune reaction may proceed toward damage and 
fibrosis. Current evidence closely links the psychological/
emotional profile of a subject with inflammation and 
harmful effects, like cardiac tissue damage (31). Myocardial 
ischemia induced by mental stress and the ‘happy heart’ 
or ‘Tako-tsubo’ syndrome are now well-defined diseases 
(1). Indeed, we have recently described (32) how proper 
stress management (for example through meditation or 
music appreciation) can reduce inflammation. Hence, 
reduced cytokines and lower expression of NFkB and 
TLR-4 receptor in peripheral blood mononuclear cells 
(PBMCs) contributed together with neuroendocrine-
immune mediators and miRNAs to improved coronary 
function (33).
A conclusive consideration
A deeper understanding of cardiovascular immunology 
and in general of systems biology (34) need a more 
comprehensive framework taking into account genetic, 
but also environmental factors and the close relationship 
existing between the environment, psyche and the 
neuroendocrine system (35). We need to evolve our 
approach to understand how single threads compose a 
sophisticated embroidery.
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